Intelligent Biomimetic Biodevice for Bone Regeneration Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical devices for treating bone degeneration often cause adverse effects due to inadequate personalized treatment and lack of real-time monitoring, leading to increased healthcare costs and potential for inflammatory reactions.
Innovation Solution
An intelligent biomimetic biodevice that communicates and activates particles in three-dimensional models using electric and magnetic stimulation, incorporating sensors and antimicrobial/therapeutic agents to monitor and control the treatment process, providing a customized and continuous assessment of bone regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional bone treatment devices are used, then treatment can be provided, but adverse effects occur and treatment costs increase due to lack of real-time monitoring and personalized control
Solution Approach 1:
The patent merges multiple functions into a single integrated biodevice: therapeutic agent delivery, real-time biosensing, wireless communication, and magnetic actuation are combined in one implantable device. This consolidation improves treatment reliability by coordinating all functions while managing complexity through integrated design rather than separate devices.
Solution Approach 2:
The device incorporates real-time feedback through biosensors that monitor treatment response and inflammatory markers. This feedback loop enables dynamic adjustment of therapeutic agent release and magnetic actuation parameters, improving safety by preventing adverse effects while the intelligent control system manages the complexity of real-time monitoring and adjustment.
2Adaptability or versatility
If real-time monitoring is implemented, then personalized treatment control is improved, but device complexity increases
Solution Approach 1:
The biodevice is designed with multi-functionality to handle various monitoring and treatment tasks through a single platform. It can deliver different therapeutic agents, monitor multiple biomarkers, and respond to various treatment scenarios, thereby achieving personalized treatment adaptability while avoiding the complexity of multiple separate devices.
Solution Approach 2:
The device performs self-monitoring and self-adjustment of treatment parameters based on real-time biosensor data. The intelligent control system automatically adjusts therapeutic agent release rates and magnetic actuation without external intervention, providing personalized treatment adaptability while reducing the complexity of external control systems.
3Reliability
If therapeutic agents are continuously delivered, then treatment efficacy is maintained, but risk of inflammatory reactions increases
Solution Approach 1:
The therapeutic agent delivery is made dynamic rather than static. The device adjusts release rates in real-time based on biosensor feedback about treatment response and inflammatory markers. This dynamic control maintains treatment efficacy by ensuring adequate drug levels while reducing inflammatory reactions by lowering doses when not needed.
Solution Approach 2:
The device employs periodic or pulsed delivery of therapeutic agents instead of continuous delivery. Magnetic actuation triggers periodic release cycles that maintain treatment efficacy through intermittent dosing while reducing cumulative inflammatory reactions compared to continuous exposure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables efficient and personalized treatment of bone degeneration by activating therapeutic agents and monitoring regeneration processes in real-time, reducing inflammation and improving treatment efficacy through dynamic control of stimulation parameters.
Implementation Method 1
The biodevice (18) is configured to communicate and activate, by means of electric and magnetic stimulation, particles incorporated in three-dimensional models (19)
Implementation Method 2
an intelligent biomimetic surface (1) comprising transducers, sensors (5, 6, 7, 8, 9) and the electric stimulation electrode (10)
Data Source
Figure 1
Figure 2A
Figure 2B
AI summary
The present invention refers to an intelligent biomimetic biodevice (18), which is configured to communicate and activate, by means of electric and magnetic stimulation, particles incorporated in three-dimensional models (19) which present properties that vary according to the intended use. The referred biodevice (18) is used in the prevention and in the treatment of diseases associated with the skeletal system, by means of the activation of the particles and release of therapeutic agents. Further, it is useful in the monitoring of the evolution of the regeneration process, by means of the monitoring of specific indicators (such as, strength, pH, oxygen, temperature and/or biomarkers). The invention appears as a therapeutic alternative for the treatment of diseases associated to bone degeneration and, further, solves the problems related to the need for real time monitoring and/or control of the chosen treatment for the disease to be treated.